Determination of lung as the primary site of cerebral metastatic adenocarcinomas using monoclonal antibody to thyroid transcription factor-1

Journal of Neuro-Oncology

Volumn 40, Issue 3, 1998, Pages 227-231

  Bohinski, R J ^a   Bejarano, P A ^a   Balko, G ^a   Warnick, R E ^a,b   Whitsett, J A ^b  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Carcinoma; Cerebral metastasis; TTF 1; Unknown primary

Indexed keywords

FORMALDEHYDE; MONOCLONAL ANTIBODY; TRANSCRIPTION FACTOR; TUMOR MARKER;

ARTICLE; ASTROCYTOMA; BRAIN METASTASIS; BREAST METASTASIS; CLINICAL ARTICLE; COLON TUMOR; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INTESTINE TUMOR; KIDNEY TUMOR; LUNG ADENOCARCINOMA; MELANOMA; PARANASAL SINUS TUMOR; PROSTATE TUMOR; STAIN; THYROID CARCINOMA; THYROID GLAND;

ADENOCARCINOMA; ANTIBODIES, MONOCLONAL; BRAIN NEOPLASMS; HUMANS; LUNG NEOPLASMS; NEOPLASMS, UNKNOWN PRIMARY; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS;

EID: 0032411470     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006102607697     Document Type: Article

References (16)

1. Nussbaum ES, Djalilian HR, Cho KH, Hall WA: Brain metastasis. Histology, multiplicity, surgery, and survival, Cancer 78: 1781-1788, 1996
2. Debevec M: Management of patients with brain metastases of unknown origin. Neoplasma 37: 601-606, 1990
3. Delattre JY, Krol G, Thaler HT, Posner JB: Distribution of brain metastases. Arch Neurol 45: 741-744, 1988
4. le Chevalier T, Smith FP, Caille P, Constans JP, Rouesse JG: Sites of primary malignancies in patients presenting with cerebral metastases: a review of 120 cases. Cancer 56: 880-882, 1985
5. Eapen L, Vachet M, Catton G, Danjoux C, McDermot R, Nair B, Girard A, Genest P, Stewart D, Gerig L; Brain metastases with an unknown primary tumor: a clinical perspective. J Neuroncol 6: 31-35, 1988
6. Salvati M, Cervoni L, Raco A: Single brain metastases from unknown primary malignancies in the CT-era. J Neuro-Onc 23: 75-80, 1995
7. Mcrchut MP: Brain metastases from undiagnosed systemic neoplasms. Arch Intern Med 149: 1076-1080, 1989
8. van de Pol M, van Aalst VC, Wilmink JT, Twijnstra A: Brain metastases from unknown primary tumour: which diagnostic procedures arc indicated? J Neurol Neurosurg Psychiatry 61: 321-323, 1996
9. Raab SS, Berg LC, Swanson PE, Wick MR: Adenocarcinoma in the lung in patients with breast cancer: a prospective analysis of the discriminatory value of immunohistology. Am J Clin Pathol 100: 27-35, 1993
10. Lazzaroo D, Price M, De Felice M, Di Lauro R: The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development 113: 1093-1104, 1991
11. Bohinski RJ, Di Lauro R, Whitsett JA: The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor-1 and hepatocyte nuclear factor-3, indicating common factors for organ-specific gene expression along the foregut axis, Mol Cell Biol 14: 5671-5681, 1994
12. Holzinger A, Dingle S, Bejarano PA, Miller MA, Weaver TE, Di Lauro R, Whitsett JA: Monoclonal antibody to thyroid transcription factor-1: production, characterization, and usefulness in tumor diagnosis. Hybridoma 15: 49-53, 1996
13. Bejarano PA, Baughman RP, Biddinger PW, Miller MA, Fenoglio-Preiser C, Al-Kafaji B, Di Lauro R, Whitsett JA: Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas. Mod Pathol 9: 445-452, 1996
14. Leong AS-Y, Wright J: The contribution of immunohistochemical staining in tumour diagnosis. Histopathology 11: 1295-1305, 1987
15. Wang NP, Zee S, Zarbo RJ, Bacchi CE, Gown AM: Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas, Appl Immunohistochem 3: 99-107, 1995
16. Perry A, Parisi JE, Kurtin PJ: Metastatic adenocarcinoma to the brain: an immunohistochemical approach. Hum Pathol 28: 938-943, 1997